SUMMARY. The increased risk of atherosclerosis in nephrotic syndrome is attributable in part to the associated hyperlipidaemia. The importance of oxidation of LDL in the atherogenic process has been recognized over the last 15 years. However, there are few data on the balance of antioxidant defences and lipoprotein oxidation in nephrotic syndrome. Plasma antioxidant vitamin concentrations and indices of LDL oxidation (LDL lipid hydroperoxide content and the susceptibility of LDL to oxidation) were measured in two groups of patients; group I comprised 29 nephrotic patients and group II comprised 25 patients with haematuria. Plasma ascorbate concentration was significantly lower in group I (the nephrotic group) compared with group II (median 13·3 versus 22·2 JJmol/L; P<O·OOI). Vitamin E concentrations were higher in group I but were not significantly different if corrected for total plasma cholesterol (6'12 versus 5·88 JJmol/mmol; P=0·33). However, these changes resulted in a low ascorbate:vitamin E ratio in group I (0'19 versus 0·87; P < 0·000I). Despite these changes in important antioxidant vitamin concentrations,
INTRODUCTION
The risk of coronary artery disease is increased significantly in patients with the nephrotic syndrome. I The severe hyperlipoproteinaemia that accompanies this syndrome is similar to the so-called 'atherogenic phenotype? [i.e. elevated LDL, low/normal HDL), variable hypertriglyceridaemia and elevated lipoprotein(a)] and probably plays a major role in the accelerated atherosclerosis. Recently, the importance of oxidized LDL in the atherogenic process has been emphasized and the potential role of antioxidants in the prevention of coronary heart disease has been tested in the general population, with variable results.' Surprisingly, there is little published information on plasma antioxidant vitamin concentrations and the state of Correspondence: Dr Graham Warwick, E-mail: gwarwickto.compuserve.com 488 LDL oxidation in nephrotic syndrome. We have investigated the plasma concentrations of the important antioxidant vitamins, E and C, other antioxidant defences and measures of LDL oxidizability in patients with nephrotic syndrome.
SUBJECTS AND METHODS
Twenty-nine patients with nephrotic syndrome (group I) were recruited from the nephrology clinics at Leicester General Hospital. The nephrotic syndrome was defined on the basis of proteinuria > 3 g/day, Patients with longstanding diabetes mellitus, severe renal failure (creatinine> 250 JJmol/L) or those treated with corticosteroids or hypolipidaemic drugs were excluded. The patients studied had been followed up for a median time of 1·1 months (range 0-291 months) from the time of renal biopsy. Five patients were on no drug therapy, 17 were taking diuretics and 16 were taking one or more antihypertensive drugs (four on IX-blockers, seven on angiotensin-converting enzyme inhibitors and eight on calcium channel blockers). Three nephrotic subjects were taking low-dose aspirin and three were taking other nonsteroidal anti-inflammatory agents. Twenty-five patients (group II) with microscopic haematuria, proteinuria <0·5 g/day, no or minimal abnormalities on renal histology and serum creatinine < 120 J,tmol/L were used for comparison. Fasting blood was colJected into EDT A or plain tubes and plasma/serum separated as soon as possible. LDL preparation started on the day of sample colJection and LDL lag time and lipid hydroperoxide content were measured immediately after LDL isolation. Samples for measurement of ascorbic acid, dehydroascorbic acid and vitamin E were kept at -80 DC for up to 2 weeks before analysis; 24-h urine samples were also colJected. Anthropometric data and current smoking status were recorded. Patients taking proprietary vitamin preparations were excluded.
Serum creatinine, albumin, cholesterol and triglyceride were measured in the routine chemical pathology laboratory. Urine total protein was measured by a sulphosalicylic acid method in the routine chemical pathology laboratory. Vitamin E was measured by highperformance liquid chromatography (HPLC) using a 5-J,tmol/L Spherisorb column (Phase Separations, UK) with UV detection at 285 nm and e-tocopherol acetate as an internal standard. The intra-and inter-assay coefficients of variation (CVs) were 6·3% and 7,3%, respectively. Ascorbic and dehydroascorbic acids were measured by HPLC using a LiChrospher IOONH 2 5-J,tmol/L column (Merck) with UV detection at 254 nm. Intra-and inter-assay CVs Were 3'5% and 4'8%, respectively. LDL oxidiz-
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ability was measured in duplicate by the conjugated diene method." LDL was isolated by serial ultracentrifugation, dialysed against phosphate-buffered saline and incubated in quartz cuvettes in a spectrophotometer at a protein concentration of 50 J,tg/mL with copper sulphate (final concentration 20 J,tmol/L). Absorption at 234 nm was measured serialJyand the lag time was calculated as described by Puhl et al. 4 The intra-assay CV (n = 6) was 9·7%. LDL lipid hydroperoxide content was measured by HPLC using phosphatidylcholine hydroperoxide as a standard and detection by chemiluminescence using microperoxidase." Intra-and inter-assay CVs were 7·4% and 1O.} %, respectively. Glutathione peroxidase was measured by enzymelinked immunosorbent assay (ELISA; Rand D systems, UK) and caeruloplasmin by radial immunodiffusion (The Binding Site, UK). Both commercial kits report intra-assay CVs of < 5%. This study was approved by the Leicestershire Health Ethics Committee and informed consent was obtained from patients for colJection of blood and urine samples. Results are given as median and inter-quartile values. Comparisons between groups were made using the MannWhitney test. Confidence intervals for differences between median values are given. Correlations were tested using Spearman's rank correlation.
RESULTS
The demographic and biochemical characteristics of the two groups are shown in Table I . Figure 1 shows the antioxidant vitamin concentrations. There was no relationship between the severity of nephrotic syndrome (measured by proteinuria or hypoalbuminaemia), age or renal function and plasma vitamin concentrations. 
. Box and whisker plots show inter-quartile points and ranges for (a) vitamin E; (b) vitamin Ettotal cholesterol ratio; (c) ascorbate; and (d) ascorbate.vitamin E ratio. Group I are in open bars. group II in filled bars. Two patients did not have vitamin E measured.
Ascorbic acid concentrations were significantly reduced in nephrotic subjects Table 2 ). Similarly, there was no difference in LDL lipid hydroperoxide content (see Table 2 ). Glutathione peroxidase and caeruloplasmin concentrations did not differ between the two groups (see Table 2 ).
DISCUSSION
The main finding of this study is a markedly reduced plasma ascorbate concentration in patients with nephrotic syndrome. The increase in plasma vitamin E concentration reflects the hypercholesterolaemia as vitamin E is transported mainly in LDL particles in the plasma. The only previous study of antioxidant vitamin concentrations in nephrotic syndrome also found an increase in vitamin E, which showed a weak inverse relation with serum albumin." The vitamin E:cholesterol ratios were not reported in that paper. We found that the plasma ascorbate:vitamin E ratio was reduced in nephrotic syndrome even if corrected for cholesterol. In vitro studies suggest that vitamin C is important in the recycling of vitamin E by reducing the tocopherol radical back to the non-radical state, thus making it available to interrupt propagation of free-radical-mediated damage to polyunsaturated fatty acid chains in lipoprotein particles.' The reduced ascorbate:vitamin E ratio may predispose to lipid peroxidation.
The explanation for the reduced plasma concentrations of ascorbate is not clear. This may reflect increased utilization by vitamin E to recycle from the radical to the non-radical state in the presence of severe hyperlipidaemia. Alternatively, there may be low dietary intake, perhaps due to dietary changes, reduced gastrointestinal absorption in nephrotic syndrome or altered renal handling of ascorbate.
Despite the differences in plasma antioxidant vitamins, we were unable to demonstrate any difference in the susceptibility of LDL to oxidation in vitro as judged by the 'lag' time of conjugated diene formation when incubated with free copper ions. Moreover, there was no difference in LDL lipid hydroperoxide content. Others have shown that a decrease in antioxidant status is not always accompanied by increases in markers of oxidative stress." Plasma concentrations may not be an accurate measure of oxidant/antioxidant balance. The antioxidant properties of vitamins C and E are important in the extravascular compartment, particularly at cell membranes and intracellularly. Leukocyte vitamin C may be a better measure of total body vitamin C stores.
In conclusion, despite severe hypercholesterolaemia and an unfavourable plasma ascorbate: vitamin E ratio, we were unable to demonstrate any changes in vitro on indices of LD L oxidation in nephrotic syndrome. The mechanism of the reduction in plasma vitamin C and whether this has any influence on the rate of development of atherosclerosis requires further study.
